We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
+15.91%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$198M
AUM Growth
-$4.31M
(-2.1%)
Cap. Flow
-$26.1M
Cap. Flow
% of AUM
-13.17%
Top 10 Holdings %
Top 10 Hldgs %
62.76%
Holding
58
New
8
Increased
9
Reduced
17
Closed
18
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.7M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$6.63M |
| 3 |
Prothena Corp
PRTA
|
+$6.46M |
| 4 |
Organogenesis Holdings
ORGO
|
+$6.4M |
| 5 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$4.93M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$13.5M |
| 2 |
uniQure
QURE
|
+$4.96M |
| 3 |
Centene
CNC
|
+$4.95M |
| 4 |
AC Immune
ACIU
|
+$4.66M |
| 5 |
Iovance Biotherapeutics
IOVA
|
+$3.97M |
Sector Composition
| 1 | Healthcare | 91.81% |
| 2 | Technology | 3.96% |
| 3 | Energy | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
CALL
Prothena Corp
PRTA
$432M
| $2.1M | 1.06% |
+175,200
| New | +$2.07M |
|
|
27
uniQure
QURE
$2.78B
| $1.95M | 0.98% |
53,900
-117,529
| -69% | -$4.96M |
|
28
ADMA Biologics
ADMA
$2.06B
| $1.72M | 0.87% |
883,214
+347,890
| +65% | +$731K |
|
29
PUT
Veracyte
VCYT
$4.83B
| $1.71M | 0.86% |
+35,000
| New | +$1.62M |
|
|
RETA
30
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.5M | 0.75% |
12,112
-102,442
| -89% | -$13.5M |
|
31
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
| $1.41M | 0.71% |
+10,000
| New | +$1.28M |
|
|
ARNA
32
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.38M | 0.7% |
+18,000
| New | +$1.35M |
|
33
Immatics
IMTX
$1.28B
| $1.13M | 0.57% |
104,999
-8,461
| -7% | -$89.2K |
|
34
ProQR Therapeutics
PRQR
$243M
| $1.07M | 0.54% |
+255,000
| New | +$1.08M |
|
35
Mirum Pharmaceuticals
MIRM
$7.34B
| $1.05M | 0.53% |
+60,250
| New | +$1.18M |
|
36
Dianthus Therapeutics
DNTH
$5.38B
| $985K | 0.5% |
7,853
-7,413
| -49% | -$840K |
|
37
PUT
ARK Genomic Revolution ETF
ARKG
$1.67B
| $933K | 0.47% |
+10,000
| New | +$797K |
|
38
PUT
Beam Therapeutics
BEAM
$3B
| $816K | 0.41% |
+10,000
| New | +$492K |
|
|
AKU
39
DELISTED
Akumin Inc
AKU
| $675K | 0.34% |
+224,273
| New | +$752K |
|
|
LHCG
40
DELISTED
LHC Group LLC
LHCG
| $586K | 0.3% |
+2,746
| New | +$585K |
|
|
41
AC Immune
ACIU
$231M
| $46K | 0.02% |
8,942
-914,175
| -99% | -$4.66M |
|
42
Moderna
MRNA
$26.6B
| $18K | 0.01% |
+174
| New | +$17.6K |
|
43
Amneal Pharmaceuticals
AMRX
$5.73B
| – | – |
-512,659
| Closed | -$1.99M |
|
44
BioXcel Therapeutics
BTAI
$27M
| – | – |
-1,863
| Closed | -$1.29M |
|
|
CLLS
45
Cellectis
CLLS
$270M
| – | – |
-185,180
| Closed | -$3.43M |
|
46
Establishment Labs
ESTA
$2.71B
| – | – |
-86,042
| Closed | -$1.59M |
|
47
Gyre Therapeutics
GYRE
$732M
| – | – |
-40,224
| Closed | -$1.3M |
|
|
48
Iovance Biotherapeutics
IOVA
$2.21B
| – | – |
-120,606
| Closed | -$3.97M |
|
49
OrthoPediatrics
KIDS
$530M
| – | – |
-8,399
| Closed | -$386K |
|
50
Kura Oncology
KURA
$985M
| – | – |
-107,367
| Closed | -$3.29M |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA